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sTATE-OF-THE-ART PAPER585Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseasesarl J. Lavie, Richard V. Milani, Mandeep R. Mehra, Hector O. Ventura
mega-3 polyunsaturated fatty acid (-3 PUFA) therapy appears to be beneficial for both
rimary and secondary prevention of cardiovascular diseases. Lavie and colleagues discuss the
vidence from retrospective epidemiologic studies and from large randomized controlled trials
emonstrating the benefits of -3 PUFA, specifically eicosapentaenoic acid (EPA) and
ocosahexaenoic acid (DHA). The potential mechanisms of these benefits are explored. The
uthors suggest that the target EPA  DHA consumption should be at least 500 mg/day for
rimary prevention and at least 800 mg/day for those with coronary heart disease or heart
ailure while further studies determine the most effective ratio of DHA to EPA.CLINICAL RESEARCH EART FAILURE595Decreased cGMP Release May Underlie Pulmonary Hypertension in CHF Patientsojtech Melenovsky, Hikmet Al-Hiti, Ludmila Kazdova, Antonin Jabor, Petr Syrovatka, Ivan Malek,
iri Kettner, Josef Kautzner
elenovsky and colleagues sought to identify factors that increase pulmonary vascular
esistance (PVR) in patients with congestive heart failure (CHF). CHF patients with high
ulmonary vascular resistance (H-PVR) (200 dyn·s·cm5) were compared with matched
HF patients with low pulmonary vascular resistance (L-PVR). H-PVR patients were then
e-examined after an oral dose of sildenafil. While transpulmonary B-type natriuretic peptide
ptake was similar, cyclic guanosine monophosphate (cGMP) release was diminished in
-PVR. H-PVR patients also had lower pulmonary artery compliance, systemic arterial
ompliance, and cardiac index. Sildenafil reduced PVR (47%), with a significant increase in
GMP. This study provides in vivo evidence that phosphodiesterase 5A inhibition restores
ensitivity of pulmonary vasculature to endogenous cGMP-dependent vasodilators.(continued on page A-23)
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EIOMARKERS601Blood Test Appears to Identify Endothelial Dysfunctionoshimitsu Nozaki, Seigo Sugiyama, Hidenobu Koga, Koichi Sugamura, Keisuke Ohba,
asushi Matsuzawa, Hitoshi Sumida, Kunihiko Matsui, Hideaki Jinnouchi, Hisao Ogawa
ndothelium-derived microparticles (EMP) are small, membrane-shed vesicles generated
rom endothelial cell surfaces in response to injury/apoptosis. Nozaki and colleagues have
reviously reported that plasma CD144-EMP levels correlate with endothelial dysfunction in
umans. In this study, the prognostic value of CD144-EMP was compared with B-type
atriuretic peptide and high-sensitivity C-reactive protein for predicting future cardiovascular
vents. All 3 biomarkers were significant, independent predictors of future cardiovascular
vents. The accuracy improved when each biomarker or combinations of biomarkers were
dded to the Framingham risk model. CD144-EMP can improve risk stratification,
resumably by more simply identifying endothelial dysfunction.EART RHYTHM DISORDERS
609uestionable Efficacy of Antiarrhythmic Drugs
for Arrhythmogenic Right Ventricular Cardiomyopathyregory M. Marcus, David V. Glidden, Bronislava Polonsky, Wojciech Zareba, Lisa M. Smith,
avid S. Cannom, N. A. Mark Estes III, Frank Marcus, Melvin M. Scheinman, for the
ultidisciplinary Study of Right Ventricular Dysplasia Investigators
ntiarrhythmic drugs are important in protecting against ventricular arrhythmias in patients
ith arrhythmogenic right ventricular cardiomyopathy (ARVC), but there is a lack of data to
uide clinical decision making. Marcus and colleagues studied the use of antiarrhythmic
edicines in all subjects with implantable cardioverter-defibrillators (ICDs) enrolled in the
orth American ARVC Registry. Sixty-one percent received beta-blockers; these medicines
ere not associated with an increased or decreased risk of ventricular arrhythmias. Sotalol was
ssociated with a greater risk of ICD shock. The 10 subjects treated with amiodarone had a
ignificantly lower risk. In ARVC subjects, neither beta-blockers nor sotalol appear to reduce
he risk of ventricular arrhythmias, but amiodarone may.ditorial Comment: L. Brent Mitchell, p. 616ARDIAC IMAGING618Echocardiographic Strain Superior to Ejection Fraction for Predicting Outcomesoo-Yeong Cho, Thomas H. Marwick, Hyun-Sook Kim, Min-Kyu Kim, Kyung-Soon Hong, Dong-Jin Oh
eft ventricular (LV) systolic function is a complex, coordinated action involving longitudinal
ontraction, circumferential shortening, and radial thickening. Contraction of muscle fibers in
he mid-wall, which is measured as circumferential strain, may better reflect intrinsic
ontractility than endocardial contraction. Cho and colleagues measured global longitudinal
train (GLS) and global circumferential strain (GCS) using 2-dimensional speckle tracking in
ver 200 patients with congestive heart failure. During follow-up, both GLS and GCS were
redictive of subsequent cardiac admissions or death. By the Cox proportional-hazards model,
CS was a powerful predictor of cardiac events that was more useful than ejection fraction.ditorial Comment: Stephane Lafitte, p. 625
(continued on page A-24)
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mARDIAC IMAGING628Determinants of Functional Capacity in Peripheral Arterial Diseaseustin D. Anderson, Frederick H. Epstein, Craig H. Meyer, Klaus D. Hagspiel, Hongkun Wang,
tuart S. Berr, Nancy L. Harthun, Arthur Weltman, Joseph M. DiMaria, Amy M. West,
hristopher M. Kramer
nderson and colleagues examined the pathophysiology of peripheral arterial disease (PAD)
y determining the relationship between large vessel obstruction, atherosclerotic plaque
urden, tissue perfusion, cellular metabolism, and functional capacity using magnetic
esonance imaging (MRI) and magnetic resonance spectroscopy (MRS) Eighty-five patients
ith mild-to-moderate PAD (mean ankle brachial index 0.69) were studied with MRI/MRS
oth at rest and after exercise. The phosphocreatine recovery time constant (PCr) at peak
xercise was the predictor of treadmill exercise time, whereas calf muscle perfusion seemed to
etermine 6-min walk distance. However, there was no correlation between PCr and tissue
erfusion. These results suggest that functional limitations in PAD are multifactorial and are
aused by both hemodynamic factors, such as atherosclerotic plaque burden, and factors that
lter cellular metabolism.ditorial Comment: Marc Dewey, p. 636PRE-CLINICAL RESEARCH RE-CLINICAL RESEARCH638Mitral Cerclage Annuloplasty: Initial Results in Swineune-Hong Kim, Ozgur Kocaturk, Cengizhan Ozturk, Anthony Z. Faranesh, Merdim Sonmez,
mita Sampath, Christina E. Saikus, Ann H. Kim, Venkatesh K. Raman, J. Andrew Derbyshire,
illiam H. Schenke, Victor J. Wright, Colin Berry, Elliot R. McVeigh, Robert J. Lederman
nspired by epicardial purse-string annuloplasty before the cardiopulmonary bypass era,
im and colleagues developed a novel catheter-based technique to reduce mitral annular
ircumference using a “cerclage” suture. The procedure, “cerclage annuloplasty,” is guided by
agnetic resonance imaging roadmaps fused with live X-ray. A coronary sinus guidewire
raverses a short segment of basal septal myocardium to re-enter the right heart, where it is
xchanged for a suture. Tension is applied until the regurgitation decreases and the degree of
ension is secured with a locking device. The technique was tested in a swine model of
schemic cardiomyopathy with good efficacy.RE-CLINICAL RESEARCH652Liposomes Can Be Filled With NO for Local Delivery to Vascular Tissueshao-Ling Huang, Patrick H. Kee, Hyunggun Kim, Melanie R. Moody, Stephen M. Chrzanowski,
obert C. MacDonald, David D. McPherson
hile nitric oxide (NO) delivery to the arterial wall has a number of potential
enefits, successful NO delivery is challenging. Huang and colleagues describe their
xperience using echogenic liposomes (ELIP) as the gas carrier. NO-ELIP results are
airly rapid, but the additional of argon (AR) gas provides a more stable, sustained
elease. NO/AR-ELIP enhanced the viability of cultured vascular smooth muscle
ells and attenuated the development of intimal hyperplasia in a rabbit vascular injury
odel. Liposomes may be an effective vehicle for delivering NO to vascular tissues.
